Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
CAPTA Reauthorization Act of 2010
Client: CHILDREN'S CANCER CAUSE · Firm: CHILDREN'S CANCER CAUSE
Childhood cancer survivorship legislation Language modifications for the Best Pharmaceuticals for Children Act and Pediatric Research Equity Act, as included in S. 3817
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
CHILDREN'S CANCER CAUSE via CHILDREN'S CANCER CAUSE
2013 · second_quarter · 2A
Childhood Cancer, Childhood Cancer Survivorship, Caroline Pryce Walker Conquer Childhood Cancer Act, Childhood Cancer Survivors' Quality of Life Act, Patients' Access to Treatments Act, NCI funding, appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHILDREN'S CANCER CAUSE via CHILDREN'S CANCER CAUSE
2013 · second_quarter · Q2
Source: Senate LDA
Childhood Cancer, Childhood Cancer Survivorship, Caroline Pryce Walker Conquer Childhood Cancer Act, Childhood Cancer Survivors' Quality of Life Act, Patients' Access to Treatments Act, NCI funding, appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHILDREN'S CANCER CAUSE via CHILDREN'S CANCER CAUSE
2013 · first_quarter · Q1
Childhood cancer issues; Childhood cancer survivorship legislation; Caroline Pryce Walker Conquer Childhood Cancer Act; NIH funding; Medicaid; CHIP; Affordable Care Act implementation; FDA Safety and Innovation Act implementation; Drug shortages; oncologic drug development
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
CHILDREN'S CANCER CAUSE via CHILDREN'S CANCER CAUSE
2012 · fourth_quarter · Q4
Childhood cancer Affordable Care Act Childhood cancer survivorship Drug development
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
CHILDREN'S CANCER CAUSE via CHILDREN'S CANCER CAUSE
2012 · third_quarter · Q3
Childhood cancer survivorship legislation Language modifications for the Best Pharmaceuticals for Children Act and Pediatric Research Equity Act, as included in S. 3817
Filing targets: HOUSE OF REPRESENTATIVES, SENATE